New Leaf Venture Management III, L.L.C.

Filings by New Leaf Venture Management III, L.L.C. span 2 companies, the busiest being Deciphera Pharmaceuticals, Inc. and Aptinyx Inc. In total, 18 filings cover trades dated from 2 October 2017 to 16 August 2019.

Both buying and selling appear: 3 purchases worth €8.9M, against 6 sales worth €11.5M. Sales outweigh purchases by €2.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2019 alone, the filings show no purchases and 6 sales.

Half of the purchases are above €1.7M and half below. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 19 August 2019, reports an open-market sale of €2.3M in Deciphera Pharmaceuticals, Inc. The most recent open-market purchase was published on 26 June 2018, 3,058 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.